Spinal cord injury (SCI) is a devastating and disabling medical condition generally caused
by a traumatic event (primary injury). This initial trauma is accompanied by a set of biological …

Exosomes are nanoscale-sized membrane vesicles released by cells into their extracellular
milieu. Within these nanovesicles reside a multitude of bioactive molecules, which …

Dysfunctional clinical outcomes following spinal cord injury (SCI) result from glial scar
formation, leading to the inhibition of new axon growth and impaired regeneration …

Biomaterials may enhance neural repair after spinal cord injury (SCI) and testing their
functionality in large animals is essential to achieve successful clinical translation. This work …

Spinal cord injury (SCI) is a disease of the central nervous system often caused by
accidents, and its prognosis is unsatisfactory, with long-term adverse effects on patients' …

Spinal cord injury (SCI) is associated with currently irreversible consequences in several
functional components of the central nervous system. Despite the severity of injury, there …

The marine-derived hyaluronic acid and other natural biopolymers offer exciting possibilities
in the field of biomaterials, providing sustainable and biocompatible alternatives to synthetic …

Spinal cord injury (SCI) substantially reduces the quality of life of affected individuals.
Recovery of function is therefore a primary concern of the patient population and a primary …

Spinal cord injury (SCI) may cause loss of motor and sensory function, autonomic
dysfunction, and thus disrupt the quality of life of patients, leading to severe disability and …

Traumatic spinal cord injuries (SCIs) continue to be a major healthcare concern, with a rising
prevalence worldwide. In response to this growing medical challenge, considerable …